FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885331395> ?p ?o ?g. }

• W2885331395 endingPage "85" @default.
• W2885331395 startingPage "79" @default.
• W2885331395 abstract "Thrombocytopenia is among the strongest predictors of decreased survival for patients with myelodysplastic syndromes (MDS) across all prognostic risk groups. The safety and efficacy of CC-486 (oral azacitidine) was investigated in early-phase studies; we assessed clinical outcomes among subgroups of MDS patients from these studies, defined by presence or lack of pretreatment thrombocytopenia (≤75 × 109/L platelet count). Patients received CC-486 300 mg once-daily for 14 or 21 days of repeated 28-day cycles. Overall, 81 patients with MDS, median age 72 years, comprised the Low Platelets (n = 45) and High Platelets (n = 36) cohorts. Pretreatment median platelet counts were 34 × 109/L and 198 × 109/L, respectively. Grade 3–4 bleeding events occurred in 2 patients in the Low Platelets and 1 patient in the High Platelets groups; events resolved without sequelae. Treatment-related mortality was reported for 7 patients, 5 of whom had pretreatment platelet values <25 × 109/L. Overall response rates were 38% and 46% in the Low Platelets and High Platelets groups, respectively. Five thrombocytopenic patients attained complete remission and 9 attained platelet hematologic improvement. In both cohorts, platelet counts dropped during the first CC-486 treatment cycle, then increased thereafter. Extended CC-486 dosing was generally well tolerated and induced hematologic responses in these patients regardless of pretreatment thrombocytopenia." @default.
• W2885331395 created "2018-08-22" @default.
• W2885331395 creator A5003121166 @default.
• W2885331395 creator A5003299911 @default.
• W2885331395 creator A5015991333 @default.
• W2885331395 creator A5017739829 @default.
• W2885331395 creator A5039230721 @default.
• W2885331395 creator A5042492175 @default.
• W2885331395 creator A5046911143 @default.
• W2885331395 creator A5061026876 @default.
• W2885331395 creator A5074629157 @default.
• W2885331395 creator A5081466882 @default.
• W2885331395 creator A5081735534 @default.
• W2885331395 date "2018-09-01" @default.
• W2885331395 modified "2023-10-15" @default.
• W2885331395 title "CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia" @default.
• W2885331395 cites W1602160610 @default.
• W2885331395 cites W1615743071 @default.
• W2885331395 cites W187238933 @default.
• W2885331395 cites W1883939012 @default.
• W2885331395 cites W1958987550 @default.
• W2885331395 cites W1967049462 @default.
• W2885331395 cites W1975352630 @default.
• W2885331395 cites W1985416137 @default.
• W2885331395 cites W1988267450 @default.
• W2885331395 cites W2015788409 @default.
• W2885331395 cites W2028751390 @default.
• W2885331395 cites W2081279521 @default.
• W2885331395 cites W2103336749 @default.
• W2885331395 cites W2103603475 @default.
• W2885331395 cites W2106082819 @default.
• W2885331395 cites W2106584820 @default.
• W2885331395 cites W2107398329 @default.
• W2885331395 cites W2117418266 @default.
• W2885331395 cites W2118771330 @default.
• W2885331395 cites W2125438418 @default.
• W2885331395 cites W2129510594 @default.
• W2885331395 cites W2132469484 @default.
• W2885331395 cites W2134292391 @default.
• W2885331395 cites W2148428508 @default.
• W2885331395 cites W2175337451 @default.
• W2885331395 cites W2265091238 @default.
• W2885331395 cites W2326726820 @default.
• W2885331395 cites W2492182383 @default.
• W2885331395 cites W2584597412 @default.
• W2885331395 doi "https://doi.org/10.1016/j.leukres.2018.08.001" @default.
• W2885331395 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30114559" @default.
• W2885331395 hasPublicationYear "2018" @default.
• W2885331395 type Work @default.
• W2885331395 sameAs 2885331395 @default.
• W2885331395 citedByCount "20" @default.
• W2885331395 countsByYear W28853313952018 @default.
• W2885331395 countsByYear W28853313952019 @default.
• W2885331395 countsByYear W28853313952020 @default.
• W2885331395 countsByYear W28853313952021 @default.
• W2885331395 countsByYear W28853313952022 @default.
• W2885331395 crossrefType "journal-article" @default.
• W2885331395 hasAuthorship W2885331395A5003121166 @default.
• W2885331395 hasAuthorship W2885331395A5003299911 @default.
• W2885331395 hasAuthorship W2885331395A5015991333 @default.
• W2885331395 hasAuthorship W2885331395A5017739829 @default.
• W2885331395 hasAuthorship W2885331395A5039230721 @default.
• W2885331395 hasAuthorship W2885331395A5042492175 @default.
• W2885331395 hasAuthorship W2885331395A5046911143 @default.
• W2885331395 hasAuthorship W2885331395A5061026876 @default.
• W2885331395 hasAuthorship W2885331395A5074629157 @default.
• W2885331395 hasAuthorship W2885331395A5081466882 @default.
• W2885331395 hasAuthorship W2885331395A5081735534 @default.
• W2885331395 hasBestOaLocation W28853313951 @default.
• W2885331395 hasConcept C104317684 @default.
• W2885331395 hasConcept C126322002 @default.
• W2885331395 hasConcept C150194340 @default.
• W2885331395 hasConcept C185592680 @default.
• W2885331395 hasConcept C190727270 @default.
• W2885331395 hasConcept C2776239401 @default.
• W2885331395 hasConcept C2777288759 @default.
• W2885331395 hasConcept C2780007613 @default.
• W2885331395 hasConcept C2780240888 @default.
• W2885331395 hasConcept C2780817109 @default.
• W2885331395 hasConcept C55493867 @default.
• W2885331395 hasConcept C71924100 @default.
• W2885331395 hasConcept C89560881 @default.
• W2885331395 hasConcept C90924648 @default.
• W2885331395 hasConceptScore W2885331395C104317684 @default.
• W2885331395 hasConceptScore W2885331395C126322002 @default.
• W2885331395 hasConceptScore W2885331395C150194340 @default.
• W2885331395 hasConceptScore W2885331395C185592680 @default.
• W2885331395 hasConceptScore W2885331395C190727270 @default.
• W2885331395 hasConceptScore W2885331395C2776239401 @default.
• W2885331395 hasConceptScore W2885331395C2777288759 @default.
• W2885331395 hasConceptScore W2885331395C2780007613 @default.
• W2885331395 hasConceptScore W2885331395C2780240888 @default.
• W2885331395 hasConceptScore W2885331395C2780817109 @default.
• W2885331395 hasConceptScore W2885331395C55493867 @default.
• W2885331395 hasConceptScore W2885331395C71924100 @default.
• W2885331395 hasConceptScore W2885331395C89560881 @default.
• W2885331395 hasConceptScore W2885331395C90924648 @default.
• W2885331395 hasFunder F4320309086 @default.

• next